Perceived effectiveness of HPV test as a primary screening modality among US providers
CP Cooper, M Saraiya - Preventive medicine, 2015 - Elsevier
Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …
Primary HPV testing: US women's awareness and acceptance of an emerging screening modality
M Saraiya, A Kwan, CP Cooper - Preventive medicine, 2018 - Elsevier
Background Primary HPV testing (without the Pap test) has recently been recommended as
a cervical cancer screening option in the United States. US women's awareness and …
a cervical cancer screening option in the United States. US women's awareness and …
Awareness and support of Clinician-and Patient-Collected human papillomavirus testing for cervical cancer screening among primary care clinicians
KL MacLaughlin, RM Jacobson… - Women's Health …, 2022 - liebertpub.com
Background: Cervical cancer screening has shifted toward human papillomavirus (HPV)-
based testing, but uptake of primary HPV screening in the United States is unknown and …
based testing, but uptake of primary HPV screening in the United States is unknown and …
Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening
VB Benard, M Saraiya, A Greek… - Journal of Women's …, 2014 - liebertpub.com
Background: The recommended screening interval when using the Papanicolaou (Pap) and
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …
human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are …
Women's acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results
LW Smith, CS Racey, L Gondara, M Krajden, M Lee… - BMJ open, 2021 - bmjopen.bmj.com
Objective To study participant's acceptability of and attitudes towards human papillomavirus
(HPV) testing compared with cytology for cervical cancer screening and what impact having …
(HPV) testing compared with cytology for cervical cancer screening and what impact having …
[HTML][HTML] Communication practices about HPV testing among providers in Federally Qualified Health Centers
L Lin, VB Benard, A Greek, KB Roland… - Preventive medicine …, 2015 - Elsevier
Objective Little is known about the information providers share with patients when ordering a
co-test, or combined human papillomavirus (HPV) and Papanicolaou (Pap) test, for cervical …
co-test, or combined human papillomavirus (HPV) and Papanicolaou (Pap) test, for cervical …
Assessing cervical cancer screening guidelines in patient education materials
KB Roland, VB Benard, M Saraiya… - Journal of Women's …, 2009 - liebertpub.com
Background: Adjunct human papillomavirus (HPV) testing with cervical cytology (Pap test) is
one option that can increase screening intervals for women aged≥ 30 years who have …
one option that can increase screening intervals for women aged≥ 30 years who have …
Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among US health care providers
JWY Lee, Z Berkowitz, M Saraiya - Obstetrics & Gynecology, 2011 - journals.lww.com
OBJECTIVE: To assess self-reported human papillomavirus (HPV) DNA testing practices by
health care providers and clinics, including nonrecommended practices such as low-risk …
health care providers and clinics, including nonrecommended practices such as low-risk …
Update on primary HPV screening for cervical cancer prevention
AE Rizzo, S Feldman - Current problems in cancer, 2018 - Elsevier
In the coming decade, primary testing for human papillomavirus (HPV) will likely become the
standard of care for cervical cancer screening in both low-and high-resource settings. This …
standard of care for cervical cancer screening in both low-and high-resource settings. This …
Are health care professionals prepared to implement human papillomavirus testing? A review of psychosocial determinants of human papillomavirus test acceptability …
O Tatar, K Wade, E McBride, E Thompson… - Journal of Women's …, 2020 - liebertpub.com
Background: Guidelines for cervical cancer screening have been updated to include human
papillomavirus (HPV) testing, which is more sensitive compared to cytology in detecting …
papillomavirus (HPV) testing, which is more sensitive compared to cytology in detecting …